BUSINESS
Infosys Q2 FY19 review: Steady execution; an ideal long term buy
Infosys posted a decent Q2 FY19 performance that saw steady execution, stable margin and strong deal wins. However, no change in FY19 revenue and margin guidance was a tad disappointing
BUSINESS
Ideas For Profit |IndusInd Bank Q2 – steady show except for the shadow of IL&FS
With most of the near-term negatives priced in, we derive comfort in the valuation at 3.2X FY20e standalone book and recommend accumulation in this weak phase.
BUSINESS
Ideas for Profit | TCS Q2 performance: Stellar show in a seasonally strong quarter
Vertical-wise, BFSI, further consolidated its position with a growth of over 6 percent. BFSI platform also showed strong acceleration. Retail, life sciences and energy continued their strength.
EARNINGS
The crisis in NBFC – well-capitalised banks will have the last laugh?
Mutual funds as a source of funding will clearly take a back seat
BUSINESS
Dozen reasons to tread this market with caution
Much of the froth is gone, but the market is still away from what can be described as mouth-watering valuations.
BUSINESS
RBI Policy: Rate hike customary, a lot more to deal with in the platter
In its last policy meeting, the RBI reverted to a 'neutral' stance and raised its benchmark repo rate. Since then, a lot has happened beyond inflation
BUSINESS
Kotak Bank-Yes Bank: A deal amid adversity?
Kotak is a savvy deal maker and has a successful track record of not over paying for what he buys
BUSINESS
Yes Bank -- avoid temptation, wait for RBI roadmap before investing
The management is portraying business as usual. But are the investors convinced?
BUSINESS
Comment | Liquidity infusion a short-term fix; IL&FS rot runs much deeper
While markets eagerly await a short-term solution, the magnitude of the problem is formidable
BUSINESS
IL&FS crisis: Why it should not become India’s Lehman moment
The owners of IL&FS are also answerable to their stakeholders and they can’t afford to throw good money after bad
BUSINESS
Ideas for Profit: Accumulate these 6 smallcaps for the long term
With the carnage in the markets, especially in the mid- and smallcap space, investors should keep these better quality smaller companies on their radar for a phased accumulation for the long term.
BUSINESS
Yes Bank – RBI acts tough, should investors worry?
Investors should exercise caution and shouldn’t bottom fish in a haste till clarity emerges on the quality of its books.
BUSINESS
IPO financing – New SEBI listing timeline may hurt NBFCs
On September 18, market regulator SEBI said companies will have to list their shares on the third day after the successful applicants have been allotted shares. Earlier, companies could do so on the sixth day after allotment.
BUSINESS
Comment | Who’s the next LIC or BoB of the beleaguered PSU banks?
Since there are many problematic banks and few with strong balance sheets, it wouldn’t be a surprise to see banks like Canara Bank and State Bank of India being dragged to the altar to take responsibility of distressed banks.
BUSINESS
Ideas for Profit: Should one avoid or bottom fish asset financing NBFCs?
Sustainability of asset growth can’t be taken for granted. The steep hike in funding cost would impact interest margin as the entire hike may not be passed on to end-customers.
BUSINESS
Comment - The rupee fall is too little to boost exports, but enough to spark rate hikes
One wonders what level of REER would give comfort to the central bank.
BUSINESS
Opinion | Will RBI adopt divergent path in treating corporate governance lapses in private banks?
If the Axis Bank board was shown tough love by the RBI, can the Yes Bank board expect anything different?
BUSINESS
MAS Financial continues its steady showing, buy for returns in the mid-20s
Despite the optically expensive valuation, we recommend stock for its consistency – a strategy that is likely to pay dividend in the long term
BUSINESS
Opinion | LIC's stake increase in IDBI Bank is funds flushed down the drain
By truly privatising the beleaguered lender, the government could have sent a strong signal to the markets of its intention of impart a new lease of life to the ailing sector.
BUSINESS
Zensar Technologies: Optimistic outlook but is it in the price?
While we expect a respectable compounded earnings of 33 percent in the next couple of years, the multiple re-rating in the past one year captures the same
BUSINESS
Safari Ind: Stellar Q1; buy for earnings visibility despite the run-up
Investors should not expect a further multiple re-rating as the same has already played out. However, one should look to accumulate this company for the secular earnings growth in the medium to long term
BUSINESS
Has the time come to look at state-run banks seriously?
We do not expect large scale capitalisation of PSBs ahead of any significant restructuring in that space. In the interim, banks without capital buffer wouldn’t be in a position to grow. Hence, we would stick to relative quality in the PSB universe.
BUSINESS
Sun Pharma Q1 review: All eyes on the speciality business
We continue to like the strong domestic business of Sun and the niche that it is trying to create with speciality in the US.
BUSINESS
Ideas for Profit: Value lurking in Equitas Holdings & Ujjivan Financial Services
With a pan-India presence and relatively high-yielding book, they remain attractive candidates for mergers and acquisitions by relatively larger entities.
